Procter & Gamble director awarded 258 RSUs

PROCTER & GAMBLE Co director Christopher J. Kempczinski reported an equity award on a Form 4.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PROCTER & GAMBLE Co director Christopher J. Kempczinski reported an equity award on a Form 4. On June 9, 2026, he acquired 258 Restricted Stock Units at $0.00 per unit under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents, bringing his reported holdings to 11,595.5466 shares/units.

Insider Trade Summary

Grant/Award: 258 shares

Grant/Award 1 txn

Insider Kempczinski Christopher J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	258	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,595.5466 shares (Direct)

Footnotes (2)

F1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
F2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Key Figures

RSU grant size: 258 units Grant price: $0.00 per unit Holdings after award: 11,595.5466 shares/units

3 metrics

RSU grant size 258 units Restricted Stock Units granted on June 9, 2026

Grant price $0.00 per unit Equity award under 2025 Stock and Incentive Compensation Plan

Holdings after award 11,595.5466 shares/units Total direct holdings following June 9, 2026 grant

Key Terms

Restricted Stock Units, dividend equivalents, Stock and Incentive Compensation Plan

3 terms

Restricted Stock Units financial

"Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend equivalents financial

"Total includes grant of dividend equivalents in the form of Restricted Stock Units."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Stock and Incentive Compensation Plan financial

"Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Christopher J. Kempczinski report in this Procter & Gamble (PG) Form 4?

Christopher J. Kempczinski reported receiving 258 Restricted Stock Units of Procter & Gamble common stock. The award was granted at $0.00 per unit under the company’s 2025 Stock and Incentive Compensation Plan, reflecting routine equity-based director compensation rather than an open-market share purchase.

When did the new Procter & Gamble (PG) Restricted Stock Units vesting event occur for Kempczinski?

The equity award for Christopher J. Kempczinski is dated June 9, 2026. On that date, he received 258 Restricted Stock Units, recorded at a price of $0.00 per unit, consistent with a stock and incentive compensation grant rather than a market transaction involving cash consideration.

How many Procter & Gamble (PG) shares or units does Kempczinski hold after this Form 4 transaction?

After the reported award, Kempczinski’s total direct holdings stand at 11,595.5466 shares or units. This total includes the 258 Restricted Stock Units granted on June 9, 2026 and prior holdings, as well as dividend equivalents credited in the form of additional Restricted Stock Units.

Was Kempczinski’s Procter & Gamble (PG) Form 4 transaction an open-market buy or sell?

The transaction was not an open-market buy or sell; it was a grant. Kempczinski acquired 258 Restricted Stock Units at $0.00 per unit as a grant or award under Procter & Gamble’s 2025 Stock and Incentive Compensation Plan, reflecting standard non-cash director compensation.

What plan governed the Procter & Gamble (PG) equity award reported by Kempczinski?

The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Footnotes specify the 258 units are Restricted Stock Units, and that his total holdings include dividend equivalents issued as additional Restricted Stock Units, aligning with the plan’s incentive compensation structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/10/2026 - 02:20 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kempczinski Christopher J

(Last)

(First)

(Middle)

1 PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI

OHIO

45202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/09/2026		A		258	A	$0⁽¹⁾	11,595.5466⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

	/s/ Wednesday Shipp, attorney-in-fact for Christopher Kempczinski	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR